DianLiang Lei WHO

Dr. Dianliang Lei obtained a PhD in medical science in Medical School of Osaka University Japan in 1996. He joined World Health Organization in 2003 as a scientist working in Technologies, Standards and Norms team, responsible for development of WHO international standards including measurement and written standards for vaccines and biological products. He has been in charge of development of WHO Guidelines for lot release of vaccines, GMP for biological products, Guidelines for post-approval changes to vaccines, Recommendations for acellular pertussis vaccines, DT-based combined vaccines, and Manual for establishment of national standards. Currently, he is responsible for the development of Guidelines on regulator preparedness in response to pandemic influenza emergency. Dr Lei was previously deputy director of National Institute for the Control of Pharmaceutical and Biological Products responsible for regulation, quality control and biological standardization of vaccines in China. He contributed to strengthen the regulation system for vaccines in China, especially on the national requirements (pharmacopeia), standards, specification for vaccines and lot release system.